• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TMC-g-PEG-VAPG/miRNA-145 复合物在用于靶向调节血管平滑肌细胞的电纺膜中的性能。

Performance of TMC-g-PEG-VAPG/miRNA-145 complexes in electrospun membranes for target-regulating vascular SMCs.

机构信息

School of Materials Science and Engineering, and Tianjin Key Laboratory of Composite and Functional Materials, Tianjin University, Tianjin 300350, China.

School of Materials Science and Engineering, and Tianjin Key Laboratory of Composite and Functional Materials, Tianjin University, Tianjin 300350, China.

出版信息

Colloids Surf B Biointerfaces. 2019 Oct 1;182:110369. doi: 10.1016/j.colsurfb.2019.110369. Epub 2019 Jul 15.

DOI:10.1016/j.colsurfb.2019.110369
PMID:31336282
Abstract

Restenosis is still one of the main challenges in small-diameter vascular regeneration, and effective modulation of vascular smooth muscle cells (SMCs) is essential to cope with the related issues. As one of microRNAs (miRNAs) in vascular systems, miRNA-145 can regulate SMCs in the normal contractile phenotype, and inhibit the excessive proliferation and intimal hyperplasia. Herein, VAPG peptide-modified trimethyl chitosan-g-poly(ethylene glycol) (TMC-g-PEG-VAPG) was developed specially for target-delivery of miRNA-145 to SMCs to fulfill the proper function. The TMC-g-PEG-VAPG/miRNA-145 complexes exhibited low cytotoxicity, and TMC-g-PEG-VAPG with relatively higher molecular weight of chitosan (50 kDa) could significantly enhance cellular uptake in SMCs. Moreover, loading with TMC-g-PEG-VAPG/miRNA-145 complexes, the electrospun membranes of poly(ethylene glycol)-b-poly(L-lactide-co-ε-caprolactone) were capable of controlling SMCs at gene and protein levels on day 3 by targeting Krüppel-like factor 4 to increase the expression of myocardin and α-smooth muscle actin. Furthermore, miRNA-145 released from the electrospun membranes also showed in vitro bioactivity of modulating the contractile phenotype of SMCs in the prolonged duration, at least 56 days. The functional electrospun membranes containing TMC-g-PEG-VAPG/miRNA-145 complexes may have a great potential in the application of small-diameter blood vessel regeneration.

摘要

血管再狭窄仍然是小直径血管再生的主要挑战之一,有效调节血管平滑肌细胞(SMC)对于应对相关问题至关重要。miRNA-145 是血管系统中的一种 microRNA,可调节正常收缩表型的 SMC,并抑制过度增殖和内膜增生。本文中,专门开发了 VAPG 肽修饰的三甲基壳聚糖-g-聚乙二醇(TMC-g-PEG-VAPG)用于将 miRNA-145 靶向递送至 SMC,以发挥适当的功能。TMC-g-PEG-VAPG/miRNA-145 复合物表现出低细胞毒性,并且相对较高分子量的壳聚糖(50 kDa)的 TMC-g-PEG-VAPG 可显著增强 SMC 中的细胞摄取。此外,负载有 TMC-g-PEG-VAPG/miRNA-145 复合物的聚乙二醇-b-聚(L-丙交酯-co-ε-己内酯)电纺膜能够通过靶向 Krüppel 样因子 4 来控制 SMC 在第 3 天的基因和蛋白水平,从而增加心肌抑制因子和 α-平滑肌肌动蛋白的表达。此外,从电纺膜释放的 miRNA-145 在体外也表现出调节 SMC 收缩表型的生物活性,持续时间至少为 56 天。含有 TMC-g-PEG-VAPG/miRNA-145 复合物的功能电纺膜在小直径血管再生的应用中具有很大的潜力。

相似文献

1
Performance of TMC-g-PEG-VAPG/miRNA-145 complexes in electrospun membranes for target-regulating vascular SMCs.TMC-g-PEG-VAPG/miRNA-145 复合物在用于靶向调节血管平滑肌细胞的电纺膜中的性能。
Colloids Surf B Biointerfaces. 2019 Oct 1;182:110369. doi: 10.1016/j.colsurfb.2019.110369. Epub 2019 Jul 15.
2
Functional electrospun fibrous scaffolds with dextran-g-poly(l-lysine)-VAPG/microRNA-145 to specially modulate vascular SMCs.具有葡聚糖-g-聚(L-赖氨酸)-VAPG/微小RNA-145的功能性电纺纤维支架,用于特异性调节血管平滑肌细胞。
J Mater Chem B. 2017 Dec 21;5(47):9312-9325. doi: 10.1039/c7tb01755c. Epub 2017 Nov 21.
3
Targeted delivery of microRNA-126 to vascular endothelial cells via REDV peptide modified PEG-trimethyl chitosan.通过REDV肽修饰的聚乙二醇-三甲基壳聚糖将微小RNA-126靶向递送至血管内皮细胞。
Biomater Sci. 2016 May 26;4(5):849-56. doi: 10.1039/c5bm00629e. Epub 2016 Apr 8.
4
Target regulation of both VECs and VSMCs by dual-loading miRNA-126 and miRNA-145 in the bilayered electrospun membrane for small-diameter vascular regeneration.双层静电纺丝膜中双重加载 miRNA-126 和 miRNA-145 对 VEC 和 VSMCs 的靶向调控用于小直径血管再生。
J Biomed Mater Res A. 2019 Feb;107(2):371-382. doi: 10.1002/jbm.a.36548. Epub 2018 Nov 21.
5
Electrospun membranes of PELCL/PCL-REDV loading with miRNA-126 for enhancement of vascular endothelial cell adhesion and proliferation.载 miRNA-126 的 PELCL/PCL-REDV 电纺膜增强血管内皮细胞黏附和增殖。
Mater Sci Eng C Mater Biol Appl. 2018 Apr 1;85:37-46. doi: 10.1016/j.msec.2017.12.005. Epub 2017 Dec 15.
6
Nanofiber-mediated microRNA-126 delivery to vascular endothelial cells for blood vessel regeneration.纳米纤维介导的微小RNA-126递送至血管内皮细胞以促进血管再生。
Acta Biomater. 2016 Oct 1;43:303-313. doi: 10.1016/j.actbio.2016.07.048. Epub 2016 Jul 28.
7
Peptide-modified PELCL electrospun membranes for regulation of vascular endothelial cells.用于调节血管内皮细胞的肽修饰聚(ε-己内酯-co-月桂酸)电纺膜
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:623-631. doi: 10.1016/j.msec.2016.06.036. Epub 2016 Jun 11.
8
A density gradient of VAPG peptides on a cell-resisting surface achieves selective adhesion and directional migration of smooth muscle cells over fibroblasts.在抗细胞表面形成 VAPG 肽的密度梯度,可实现平滑肌细胞对成纤维细胞的选择性黏附和定向迁移。
Acta Biomater. 2018 May;72:70-81. doi: 10.1016/j.actbio.2018.04.005. Epub 2018 Apr 7.
9
Electrospun PELCL membranes loaded with QK peptide for enhancement of vascular endothelial cell growth.负载QK肽的静电纺丝PELCL膜用于促进血管内皮细胞生长。
J Mater Sci Mater Med. 2016 Jun;27(6):106. doi: 10.1007/s10856-016-5705-6. Epub 2016 Apr 23.
10
Receptor-mediated gene delivery by folate-poly(ethylene glycol)-grafted-trimethyl chitosan in vitro.叶酸-聚乙二醇-接枝-三甲基壳聚糖通过受体介导的体外基因递送。
J Drug Target. 2011 Sep;19(8):647-56. doi: 10.3109/1061186X.2010.525650. Epub 2010 Oct 22.

引用本文的文献

1
Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.用于心血管再生中靶向递送微小RNA的工程纳米颗粒和生物支架——综述
FASEB J. 2025 Jul 31;39(14):e70871. doi: 10.1096/fj.202501226RR.
2
Biomaterial-based vascularization strategies for enhanced treatment of peripheral arterial disease.基于生物材料的血管生成策略用于增强外周动脉疾病的治疗
J Nanobiotechnology. 2025 Feb 12;23(1):103. doi: 10.1186/s12951-025-03140-4.
3
Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine.
微小RNA整合组织工程策略发展的当前进展:再生医学的基石
Front Bioeng Biotechnol. 2024 Oct 16;12:1484151. doi: 10.3389/fbioe.2024.1484151. eCollection 2024.
4
Hybrid fibrous architectures-mediated gene transfer by pDNA nanoparticles into macrophages.混合纤维结构介导的质粒DNA纳米颗粒向巨噬细胞的基因转移。
Heliyon. 2024 Sep 25;10(19):e38071. doi: 10.1016/j.heliyon.2024.e38071. eCollection 2024 Oct 15.
5
Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.用于核酸递送的壳聚糖基纳米颗粒:技术层面、应用及未来展望
Pharmaceutics. 2023 Jun 29;15(7):1849. doi: 10.3390/pharmaceutics15071849.
6
Chitosan Based MicroRNA Nanocarriers.基于壳聚糖的微小RNA纳米载体
Pharmaceuticals (Basel). 2022 Aug 23;15(9):1036. doi: 10.3390/ph15091036.
7
Electrospun-Fibrous-Architecture-Mediated Non-Viral Gene Therapy Drug Delivery in Regenerative Medicine.电纺纤维结构介导的非病毒基因治疗药物递送在再生医学中的应用
Polymers (Basel). 2022 Jun 29;14(13):2647. doi: 10.3390/polym14132647.
8
Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools.设计用于高效传递遗传物质和基因组编辑工具的静电纺丝纤维平台。
Adv Drug Deliv Rev. 2022 Apr;183:114161. doi: 10.1016/j.addr.2022.114161. Epub 2022 Feb 17.
9
Electrospun nanofiber scaffold for vascular tissue engineering.用于血管组织工程的静电纺纳米纤维支架。
Mater Sci Eng C Mater Biol Appl. 2021 Oct;129:112373. doi: 10.1016/j.msec.2021.112373. Epub 2021 Aug 14.